Foundations of Clinical Practice
Dermatology
Pulmonary Medicine
Pulmonary Medicine 2
Common Symptoms
100

Structured communication strategies to improve handoffs

I-PASS, call-outs, SBAR, closed-loop communication

100

Highest-potency formulation among dermatologic ointments, solutions, and suspensions

Ointments

100

First step in evaluating excessive daytime sleepiness

Actigraphy or sleep diary

100

Ventilatory treatment of acute hypercapnic respiratory failure from OHS

BPAP

100

Medication class most associated with acute cough

ACE inhibitors

200

Perioperative management of aspirin for secondary prevention

Continue perioperatively for elective noncardiac surgery

200

Diagnosis of edema, erythema, and tenderness around the nail fold

Acute paronychia

200

Most common cause of excessive daytime sleepiness

Insufficient sleep syndrome

200

Initial imaging for CTEPH

V/Q scan

200

Most common cause of lower extremity ulcers

Venous stasis

300

Contributors of suboptimal care transitions

Poor communication among team; inadequate information transfer and patient education

300

Most common malignant diseases associated with pruritus

Hodgkin lymphoma, polycythemia vera

300

Common symptoms of bronchiectasis

Chronic productive cough, frequent respiratory infections

300

Initial test for PH

Transthoracic echocardiography

300

Medial-inferior heel pain after prolonged rest (e.g. first morning steps), improved with walking

Plantar fasciitis

400

Most common cause of postoperative hypoxia

Atelectasis

400

Pigmented macule with a surrounding hypopigmentation

Halo nevus

400

Most common causes of lymphocyte-predominant pleural effusion

TB, cancer

400

Treatment for CTEPH

Pulmonary thromboendarterectomy and anticoagulation

400

Diagnosis for elbow pain with flexion, paresthesia/numbness in 4th to 5th digits

Ulnar nerve entrapment

500

Genetic testing before prescribing allopurinol

HLA-B*58:01

500

Part of the body where adverse effects of high-potency topical glucocorticoids are most commonly seen

Face and intertriginous areas (e.g. skin folds)

500

Treatment for poorly controlled asthma, elevated IgE, and allergies

Omalizumab

500

COPD indications for supplemental oxygen

PO₂ ≤55 mm Hg, SpO₂ ≤88%

500

Cause of arm paresthesia/pain worsened with activity and arm elevation

Neurogenic thoracic outlet syndrome

M
e
n
u